Yesterday, Oct. 27, 2015, 46 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $9.70 to $8,186,902.01.

Highlighted Stocks Traded by Insiders:

Idex (IEX) - FREE Research Report

Mitts Heath A, who is SVP - Chief Financial Officer at Idex, sold 8,019 shares at $76.67 on Oct. 27, 2015. Following this transaction, the SVP - Chief Financial Officer owned 29,314 shares meaning that the stake was reduced by 21.48% with the 8,019-share transaction.

Ashleman Eric D, who is Chief Operating Officer at Idex, sold 6,200 shares at $76.87 on Oct. 27, 2015. Following this transaction, the Chief Operating Officer owned 25,667 shares meaning that the stake was reduced by 19.46% with the 6,200-share transaction.

The shares most recently traded at $76.87, down $0.00, or 0% since the insider transaction. Historical insider transactions for Idex go as follows:

  • 4-Week # shares sold: 3,154
  • 12-Week # shares sold: 3,154
  • 24-Week # shares sold: 5,372

The average volume for Idex has been 469,800 shares per day over the past 30 days. Idex has a market cap of $5.9 billion and is part of the industrial goods sector and industrial industry. Shares are down 1.91% year-to-date as of the close of trading on Tuesday.

IDEX Corporation, through its subsidiaries, provides various pumps, flow meters, other fluidics systems and components, and engineered products worldwide. The stock currently has a dividend yield of 1.67%. The company has a P/E ratio of 22.7. Currently, there are 3 analysts who rate Idex a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IEX - FREE

TheStreet Quant Ratings

rates Idex as a

buy

. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full

Idex Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

comScore (SCOR) - FREE Research Report

Brown Michael Andrew, who is Chief Technology Officer at comScore, sold 400 shares at $43.24 on Oct. 27, 2015. Following this transaction, the Chief Technology Officer owned 23,635 shares meaning that the stake was reduced by 1.66% with the 400-share transaction.

The shares most recently traded at $42.47, down $0.77, or 1.81% since the insider transaction. Historical insider transactions for comScore go as follows:

  • 4-Week # shares sold: 5,100
  • 12-Week # shares sold: 113,139
  • 24-Week # shares sold: 224,471

The average volume for comScore has been 496,300 shares per day over the past 30 days. comScore has a market cap of $1.7 billion and is part of the services sector and diversified services industry. Shares are down 8.81% year-to-date as of the close of trading on Tuesday.

comScore, Inc. provides digital media analytics products and services for content publishers, advertisers, advertising agencies, and network operators primarily in the United States, Canada, Europe, Latin America, and Asia. Currently, there are 5 analysts who rate comScore a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SCOR - FREE

TST Recommends

TheStreet Quant Ratings

rates comScore as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full

comScore Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Neuralstem (CUR) - FREE Research Report

Johe Karl, who is Chief Scientific Officer at Neuralstem, sold 25,000 shares at $1.13 on Oct. 27, 2015. Following this transaction, the Chief Scientific Officer owned 901,304 shares meaning that the stake was reduced by 2.7% with the 25,000-share transaction.

The shares most recently traded at $1.02, down $0.11, or 10.55% since the insider transaction. Historical insider transactions for Neuralstem go as follows:

  • 4-Week # shares bought: 14,250
  • 4-Week # shares sold: 75,000
  • 12-Week # shares bought: 14,250
  • 12-Week # shares sold: 125,000
  • 24-Week # shares bought: 14,250
  • 24-Week # shares sold: 125,000

The average volume for Neuralstem has been 435,200 shares per day over the past 30 days. Neuralstem has a market cap of $101.0 million and is part of the health care sector and drugs industry. Shares are down 62.5% year-to-date as of the close of trading on Tuesday.

Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of regenerative medicine treatments based on its human neuronal stem cells and small molecule compounds. Currently, there are 2 analysts who rate Neuralstem a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CUR - FREE

TheStreet Quant Ratings

rates Neuralstem as a

sell

. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full

Neuralstem Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.